Fda, Experimental Drugs | featured news

FDA questions safety of experimental diabetes drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...

 

FDA rejects anticipated diet pill Qnexa

FDA rejects anticipated diet pill Qnexa

Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.

 

Subscribe to this RSS topic: Syndicate content